Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

In our strange new AI reality, I put the top AI video generators to the test to find the ultimate winner. Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and ...